Английская Википедия:Benitec Biopharma
Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску
Шаблон:Use Australian English Шаблон:Use dmy dates
Шаблон:Infobox company Benitec Biopharma Limited (Шаблон:ASX) is an Australian biotechnology company founded in 1997.[1] It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference (ddRNAi) technology.[2]
The CSIRO has researched RNAi extensively, developing the small hairpin RNA concept employed in ddRNAi. Benitec Biopharma has an exclusive license to this ddRNAi technology in human therapeutic uses and research.[3]
Research and development
Benitec Biopharma is researching ddRNAi in the following fields:
- Hepatitis B (under development with partner Biomics Biotechnologies)[4])
- Oculopharyngeal muscular dystrophy (OPMD)[5][6]
References
External links
Категории:
- Английская Википедия
- Biotechnology companies of Australia
- Stem cells
- Biopharmaceutical companies
- Genetic engineering
- Companies based in Sydney
- Multinational companies headquartered in Australia
- Biotechnology companies established in 1997
- Companies listed on the Nasdaq
- Companies formerly listed on the Australian Securities Exchange
- Australian brands
- Pharmaceutical companies established in 1997
- Australian companies established in 1997
- Science and technology in Melbourne
- Страницы, где используется шаблон "Навигационная таблица/Телепорт"
- Страницы с телепортом
- Википедия
- Статья из Википедии
- Статья из Английской Википедии